KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio: 2009-2024

Historic Asset Utilization Ratio for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to 0.40.

  • Teva Pharmaceutical Industries' Asset Utilization Ratio rose 3.91% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year increase of 3.91%. This contributed to the annual value of 0.40 for FY2024, which is 10.31% up from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Asset Utilization Ratio of 0.40 as of FY2024, which was up 10.31% from 0.36 recorded in FY2023.
  • In the past 5 years, Teva Pharmaceutical Industries' Asset Utilization Ratio registered a high of 0.40 during FY2024, and its lowest value of 0.31 during FY2020.
  • In the last 3 years, Teva Pharmaceutical Industries' Asset Utilization Ratio had a median value of 0.36 in 2023 and averaged 0.36.
  • Data for Teva Pharmaceutical Industries' Asset Utilization Ratio shows a peak YoY increased of 11.25% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Teva Pharmaceutical Industries' Asset Utilization Ratio stood at 0.31 in 2020, then rose by 4.82% to 0.32 in 2021, then increased by 0.79% to 0.33 in 2022, then rose by 11.25% to 0.36 in 2023, then rose by 10.31% to 0.40 in 2024.